Well Referenced

Tag: Anthroposophic medicine

Intravenous Mistletoe Treatment in Integrative Cancer Care: A Qualitative Study Exploring the Procedures, Concepts, and Observations of Expert Doctors

This 2016 qualitative study explored the use of intravenous mistletoe therapy (MT) in integrative cancer care through interviews with 35 experienced physicians specializing in anthroposophic medicine. The study found that MT is employed to stabilize disease, induce fever, enhance quality of life, and improve the tolerability of conventional treatments. Physicians

Read More »
June 26, 2025 No Comments

Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology

This study investigates the safety and adverse effects of intratumoral (IT) mistletoe injections in 123 cancer patients, examining the incidence and severity of adverse drug reactions (ADRs) from 862 injections using preparations like Abnoba Viscum and Helixor. The study found that 21.1% of patients experienced mild ADRs, including localized reactions

Read More »
June 26, 2025 No Comments

Adverse Drug Reactions and Expected Effects to Therapy With Subcutaneous Mistletoe Extracts (Viscum Album L.) in Cancer Patients

This observational study assessed the safety and adverse drug reactions (ADRs) of subcutaneous mistletoe (Viscum album) extract in cancer patients. A total of 1,923 patients receiving mistletoe as part of anthroposophic medicine were observed, with 14.7% reporting expected effects such as local reactions and mild fever. Only 8.4% of patients

Read More »
June 26, 2025 No Comments

Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts

This systematic review analyzed 16 randomized controlled trials (RCTs), 9 non-randomized controlled trials (N-RCTs), and 12 single-arm cohort studies to evaluate the effects of anthroposophic mistletoe extract (Viscum album) in cancer therapy. Of the 17 trials assessing survival, 8 (including 5 of 10 RCTs) reported statistically significant benefits; however, no

Read More »
June 26, 2025 No Comments

Fever Therapy With Intravenously Applied Mistletoe Extracts for Cancer Patients: A Retrospective Study

This 2017 retrospective observational study (Integrative Cancer Therapies, PMID: 27387685) investigated the safety and immune-stimulating effects of intravenously applied mistletoe extracts (IAMPs) in 59 cancer patients receiving 567 total infusions. Fever (≥38.5°C) was successfully induced in 76% of patients, with an average temperature increase of 1.5°C. Most adverse events were

Read More »
June 26, 2025 No Comments